skip to main content
Idioma:
Refinado por: Nome da Publicação: Leukemia remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms
Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms
Material Type:
Artigo 		Adicionar ao Meu Espaço

Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms

Walker, Brian A ; Wardell, Christopher P ; Melchor, Lorenzo ; Brioli, Annamaria ; Johnson, David C ; Kaiser, Martin F ; Mirabella, Fabio ; Lopez-Corral, Lucia ; Humphray, Sean ; Murray, Lisa ; Ross, Mark ; Bentley, David ; Gutiérrez, Norma C ; Garcia-Sanz, Ramón ; San Miguel, Jesus ; Davies, Faith E ; Gonzalez, David ; Morgan, Gareth J

Leukemia, 2014-02, Vol.28 (2), p.384-390 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
2
Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling
Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling
Material Type:
Artigo 		Adicionar ao Meu Espaço

Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling

GUTIERREZ, N. C ; SARASQUETE, M. E ; HERNANDEZ, J. M ; GARCIA-SANZ, R ; GONZALEZ, M ; SAN MIGUEL, J. F ; MISIEWICZ-KRZEMINSKA, I ; DELGADO, M ; DE LAS RIVAS, J ; TICONA, F. V ; FERMINAN, E ; MARTIN-JIMENEZ, P ; CHILLON, C ; RISUENO, A

Leukemia, 2010-03, Vol.24 (3), p.629-637 [Periódico revisado por pares]

Avenel, NJ: Nature Publishing Group

Texto completo disponível

Citações Citado por
3
Differentiation stage of myeloma plasma cells: biological and clinical significance
Differentiation stage of myeloma plasma cells: biological and clinical significance
Material Type:
Artigo 		Adicionar ao Meu Espaço

Differentiation stage of myeloma plasma cells: biological and clinical significance

Paiva, B ; Puig, N ; Cedena, M T ; de Jong, B G ; Ruiz, Y ; Rapado, I ; Martinez-Lopez, J ; Cordon, L ; Alignani, D ; Delgado, J A ; van Zelm, M C ; Van Dongen, J J M ; Pascual, M ; Agirre, X ; Prosper, F ; Martín-Subero, J I ; Vidriales, M-B ; Gutierrez, N C ; Hernandez, M T ; Oriol, A ; Echeveste, M A ; Gonzalez, Y ; Johnson, S K ; Epstein, J ; Barlogie, B ; Morgan, G J ; Orfao, A ; Blade, J ; Mateos, M V ; Lahuerta, J J ; San-Miguel, J F

Leukemia, 2017-02, Vol.31 (2), p.382-392 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
Multiparameter flow cytometry for the identification of the Waldenström's clone in IgM-MGUS and Waldenström's Macroglobulinemia: new criteria for differential diagnosis and risk stratification
Multiparameter flow cytometry for the identification of the Waldenström's clone in IgM-MGUS and Waldenström's Macroglobulinemia: new criteria for differential diagnosis and risk stratification
Material Type:
Artigo 		Adicionar ao Meu Espaço

Multiparameter flow cytometry for the identification of the Waldenström's clone in IgM-MGUS and Waldenström's Macroglobulinemia: new criteria for differential diagnosis and risk stratification

Paiva, B ; Montes, M C ; García-Sanz, R ; Ocio, E M ; Alonso, J ; de Las Heras, N ; Escalante, F ; Cuello, R ; de Coca, A G ; Galende, J ; Hernández, J ; Sierra, M ; Martin, A ; Pardal, E ; Bárez, A ; Alonso, J ; Suarez, L ; González-López, T J ; Perez, J J ; Orfao, A ; Vidríales, M-B ; San Miguel, J F

Leukemia, 2014-01, Vol.28 (1), p.166-173 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
5
Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network
Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network

Ludwig, Heinz ; Delforge, Michel ; Facon, Thierry ; Einsele, Hermann ; Gay, Francesca ; Moreau, Philippe ; Avet-Loiseau, Hervé ; Boccadoro, Mario ; Hajek, Roman ; Mohty, Mohamad ; Cavo, Michele ; Dimopoulos, Meletios A ; San-Miguel, Jesús F ; Terpos, Evangelos ; Zweegman, Sonja ; Garderet, Laurent ; Mateos, María-Victoria ; Cook, Gordon ; Leleu, Xavier ; Goldschmidt, Hartmut ; Jackson, Graham ; Kaiser, Martin ; Weisel, Katja ; van de Donk, Niels W C J ; Waage, Anders ; Beksac, Meral ; Mellqvist, Ulf H ; Engelhardt, Monika ; Caers, Jo ; Driessen, Christoph ; Bladé, Joan ; Sonneveld, Pieter

Leukemia, 2018-07, Vol.32 (7), p.1542-1560 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
6
Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation : t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosis
Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation : t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation : t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosis

GUTIERREZ, N. C ; CASTELLANOS, M. V ; PALOMERA, L ; GARDELLA, S ; ESCODA, L ; HERNANDEZ-BOLUDA, J. C ; BELLO, J. L ; DE LA RUBIA, J ; LAHUERTA, J. J ; SAN MIGUEL, J. F ; MARTIN, M. L ; MATEOS, M. V ; HERNANDEZ, J. M ; FERNANDEZ, M ; CARRERA, D ; ROSINOL, L ; RIBERA, J. M ; OJANGUREN, J. M

Leukemia, 2007, Vol.21 (1), p.143-150 [Periódico revisado por pares]

London: Nature Publishing

Texto completo disponível

Citações Citado por
7
LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma
LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma

Mateos, Maria-Victoria ; Weisel, Katja ; De Stefano, Valerio ; Goldschmidt, Hartmut ; Delforge, Michel ; Mohty, Mohamad ; Cavo, Michele ; Vij, Ravi ; Lindsey-Hill, Joanne ; Dytfeld, Dominik ; Angelucci, Emanuele ; Perrot, Aurore ; Benjamin, Reuben ; van de Donk, Niels W C J ; Ocio, Enrique M ; Scheid, Christof ; Gay, Francesca ; Roeloffzen, Wilfried ; Rodriguez-Otero, Paula ; Broijl, Annemiek ; Potamianou, Anna ; Sakabedoyan, Caline ; Semerjian, Maria ; Keim, Sofia ; Strulev, Vadim ; Schecter, Jordan M ; Vogel, Martin ; Wapenaar, Robert ; Nesheiwat, Tonia ; San-Miguel, Jesus ; Sonneveld, Pieter ; Einsele, Hermann ; Moreau, Philippe

Leukemia, 2022-05, Vol.36 (5), p.1371-1376 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
The bone marrow niche regulates redox and energy balance in MLL::AF9 leukemia stem cells
The bone marrow niche regulates redox and energy balance in MLL::AF9 leukemia stem cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

The bone marrow niche regulates redox and energy balance in MLL::AF9 leukemia stem cells

Viñado, Ana C ; Calvo, Isabel A ; Cenzano, Itziar ; Olaverri, Danel ; Cocera, Miguel ; San Martin-Uriz, Patxi ; Romero, Juan P ; Vilas-Zornoza, Amaia ; Vera, Laura ; Gomez-Cebrian, Nuria ; Puchades-Carrasco, Leonor ; Lisi-Vega, Livia E ; Apaolaza, Iñigo ; Valera, Pablo ; Guruceaga, Elisabeth ; Granero-Molto, Froilan ; Ripalda-Cemborain, Purificacion ; Luck, Tamara J ; Bullinger, Lars ; Planes, Francisco J ; Rifon, José J ; Méndez-Ferrer, Simón ; Yusuf, Rushdia Z ; Pardo-Saganta, Ana ; Prosper, Felipe ; Saez, Borja

Leukemia, 2022-08, Vol.36 (8), p.1969-1979 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
9
Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99) : benefit of an early intervention
Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99) : benefit of an early intervention
Material Type:
Artigo 		Adicionar ao Meu Espaço

Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99) : benefit of an early intervention

ESTEVE, J ; ESCODA, L ; TOMAS, J. F ; TORMO, M ; SAYAS, M. J ; SANCHEZ GODOY, P ; COLOMER, D ; BOLUFER, P ; SANZ, M. A ; MARTIN, G ; RUBIO, V ; DIAZ-MEDIAVILLA, J ; GONZALEZ, M ; RIVAS, C ; ALVAREZ, C ; GONZALEZ SAN MIGUEL, J. D ; BRUNET, S

Leukemia, 2007-03, Vol.21 (3), p.446-452 [Periódico revisado por pares]

London: Nature Publishing

Texto completo disponível

Citações Citado por
10
Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myeloma
Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myeloma

Martinez-Lopez, J ; Sanchez-Vega, B ; Barrio, S ; Cuenca, I ; Ruiz-Heredia, Y ; Alonso, R ; Rapado, I ; Marin, C ; Cedena, M-T ; Paiva, B ; Puig, N ; Mateos, M-V ; Ayala, R ; Hernández, M-T ; Jimenez, C ; Rosiñol, L ; Martínez, R ; Teruel, A-I ; Gutiérrez, N ; Martin-Ramos, M-L ; Oriol, A ; Bargay, J ; Bladé, J ; San-Miguel, J ; Garcia-Sanz, R ; Lahuerta, J-J

Leukemia, 2017-06, Vol.31 (6), p.1446-1449 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.